Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06595420 · ClinicalTrials.gov registry record
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
A clinical trial of Acute Kidney Injury and Cystic Fibrosis (CF), sponsored by University of Virginia.
- Recruiting
- Registry status
- 260
- Enrollment target
- 3
- Study locations
NCT06595420: Recruiting study of Acute Kidney Injury and Cystic Fibrosis (CF), sponsored by University of Virginia.
NCT06595420 is a study of Acute Kidney Injury and Cystic Fibrosis (CF) that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 260 participants, below the 2,327-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06595420, a study of Acute Kidney Injury and Cystic Fibrosis (CF), is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who is at risk or detect kidney damage early before it becomes permanent. The study will compare these markers in people with CF over time and during the treatment of lung flare-ups. It will also compare the blood and urine samples obtained from people without CF. The comparison aims to better understand the impact of cystic fibrosis and its treatment on the kidneys, as well as to develop improved methods for preventing, diagnosing, and treating kidney issues associated with CF.
Primary Outcome
Outpatient CF Cohort
Conditions Studied
Study Locations (3)
Alabama
- University of Alabama at Birmingham - Birmingham
New Hampshire
- Dartmouth-Hitchcock Geisel School of Medicine at Dartmouth - Lebanon
Virginia
- University of Virginia Children's Hospital - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2025-01-09 |
| Est. Completion | 2027-12 |
What NCT06595420 shows while recruiting
NCT06595420 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 2,327-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 0 interventions.
NCT06595420 reports a single indexed study location in Alabama, New Hampshire, Virginia.
Frequently Asked Questions
What is clinical trial NCT06595420 about?
NCT06595420 is a clinical study titled "Kidney Function in People With Cystic Fibrosis in the Era of HEMT". The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who is at risk or detect kidney damage early before it becomes permanent. The study will compare these markers in people with ...
What is the current status of trial NCT06595420?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2025-01-09. Estimated completion is 2027-12.
What conditions does trial NCT06595420 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Cystic Fibrosis (CF), Chronic Kidney Disease (CKD).
Who is sponsoring clinical trial NCT06595420?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06595420 being conducted?
This trial has 3 study locations across Alabama, New Hampshire, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06595420's enrollment target sits among peer trials
260 28th of 74 higher than 47 of 74 other Acute Kidney Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Kidney Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI